Recent Quotes (30 days)

You have no recent quotes
chg | %

Check Cap Ltd  

(Public, NASDAQ:CHEK)   Watch this stock  
Find more results for CHEK
0.950
+0.040 (4.40%)
Dec 15 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.88 - 0.97
52 week 0.80 - 2.64
Open 0.92
Vol / Avg. 159,272.00/250,800.00
Mkt cap 16.14M
P/E     -
Div/yield     -
EPS -0.61
Shares 16.99M
Beta     -
Inst. own 27%
Mar 7, 2018
Q4 2017 Check Cap Ltd Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 6, 2017
Q3 2017 Check Cap Ltd Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -106.95% -63.97%
Return on average equity -144.99% -76.56%
Employees 39 -
CDP Score - -

Address


+972-4-8303401 (Phone)
+972-4-8211267 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient's back, and a personal computer (PC)-based work station for data reconstruction and image processing. The Company's scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Its scanning capsule employs low-dose X-rays, which allow the system to image the interior lining of the colon even when surrounded by intestinal content. Its capsule transmits information to a receiving device worn on the patient's body that stores the information for off-line analysis.

Officers and directors

Tomer Kariv Chairman of the Board
Age: 56
Bio & Compensation  - Reuters
William Densel Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Lior Torem CPA Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Yoav Kimchy Ph.D. Chief Technology Officer
Age: 54
Bio & Compensation  - Reuters
Alex Ovadia Vice President - Research & Development
Age: 53
Bio & Compensation  - Reuters
Mary Jo Gorman M.D. External Director
Age: 56
Bio & Compensation  - Reuters
XiangQian Lin Director
Age: 32
Bio & Compensation  - Reuters
Walter L. Robb Ph.D. Director
Age: 87
Bio & Compensation  - Reuters
Yuval Yanai External Director
Age: 65
Bio & Compensation  - Reuters
Steven J. Hanley Independent Director
Age: 48
Bio & Compensation  - Reuters